Tokyo Tape
Sign in
← GNI Group

Quarterly report · Q3

2160.TEDINET S100PN1P
Period2022-01-01 → 2022-09-30
Filed2022-11-14
StandardIFRS
ConsolidatedYes
Data checks16 of 16 passed
Key figures · 62
MetricValuePeriodScopeSource row
Revenue¥12.8bn2022-01-01 → 2022-09-30Cons.Revenue IFRS
Revenue¥4.6bn2022-07-01 → 2022-09-30dCons.Revenue IFRS
Revenue¥12.7bn2021-01-01 → 2021-12-31Cons.Revenue IFRS (5-year summary)
Revenue¥9.5bn2021-01-01 → 2021-09-30Cons.Revenue IFRS
Revenue¥3.1bn2021-07-01 → 2021-09-30dCons.Revenue IFRS
Operating income¥1.5bn2022-01-01 → 2022-09-30Cons.Operating profit loss IFRS
Operating income¥490m2022-07-01 → 2022-09-30dCons.Operating profit loss IFRS
Operating income¥2.0bn2021-01-01 → 2021-09-30Cons.Operating profit loss IFRS
Operating income¥505m2021-07-01 → 2021-09-30dCons.Operating profit loss IFRS
Profit before tax¥1.2bn2022-01-01 → 2022-09-30Cons.Profit loss before tax IFRS
Profit before tax¥433m2022-07-01 → 2022-09-30dCons.Profit loss before tax IFRS
Profit before tax¥1.1bn2021-01-01 → 2021-12-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥1.6bn2021-01-01 → 2021-09-30Cons.Profit loss before tax IFRS
Profit before tax¥371m2021-07-01 → 2021-09-30dCons.Profit loss before tax IFRS
Net income (owners)¥1.1bn2022-01-01 → 2022-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥400m2022-07-01 → 2022-09-30dCons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥1.1bn2021-01-01 → 2021-12-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥1.3bn2021-01-01 → 2021-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥353m2021-07-01 → 2021-09-30dCons.Profit loss attributable to owners of parent IFRS
Net income¥324m2022-01-01 → 2022-09-30Cons.Profit loss IFRS
Net income¥126m2022-07-01 → 2022-09-30dCons.Profit loss IFRS
Net income¥55m2021-01-01 → 2021-12-31Cons.Profit loss IFRS (5-year summary)
Net income¥875m2021-01-01 → 2021-09-30Cons.Profit loss IFRS
Net income¥130m2021-07-01 → 2021-09-30dCons.Profit loss IFRS
Total assets¥36.5bnat 2022-09-30Cons.Assets IFRS
Total assets¥30.3bnat 2021-12-31Cons.Assets IFRS
Total assets¥29.8bnat 2021-09-30Cons.Total assets IFRS (5-year summary)
Total liabilities¥14.4bnat 2022-09-30Cons.Liabilities IFRS
Total liabilities¥11.0bnat 2021-12-31Cons.Liabilities IFRS
Net assets / equity¥22.0bnat 2022-09-30Cons.Equity IFRS
Net assets / equity¥19.3bnat 2021-12-31Cons.Equity IFRS
Net assets / equity¥19.4bnat 2021-09-30Cons.Equity IFRS
Net assets / equity¥12.8bnat 2020-12-31dCons.Equity IFRS
Equity (owners)¥22.9bnat 2022-09-30Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥18.9bnat 2021-12-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥18.5bnat 2021-09-30Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥12.7bnat 2022-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥14.4bnat 2021-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥13.9bnat 2021-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥10.3bnat 2020-12-31dCons.Cash and cash equivalents IFRS
Operating cash flow−¥163m2022-01-01 → 2022-09-30Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥552m2021-01-01 → 2021-12-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥755m2021-01-01 → 2021-09-30Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥2.9bn2022-01-01 → 2022-09-30Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥261m2021-01-01 → 2021-12-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥884m2021-01-01 → 2021-09-30Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥299m2022-01-01 → 2022-09-30Cons.Net cash provided by used in financing activities IFRS
Financing cash flow¥2.9bn2021-01-01 → 2021-12-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow¥3.2bn2021-01-01 → 2021-09-30Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥22.672022-01-01 → 2022-09-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥8.422022-07-01 → 2022-09-30dCons.Basic earnings loss per share IFRS
EPS (basic)¥22.722021-01-01 → 2021-12-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥27.692021-01-01 → 2021-09-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥7.442021-07-01 → 2021-09-30dCons.Basic earnings loss per share IFRS
EPS (diluted)¥22.462022-01-01 → 2022-09-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥8.282022-07-01 → 2022-09-30dCons.Diluted earnings loss per share IFRS
EPS (diluted)¥22.082021-01-01 → 2021-12-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥26.872021-01-01 → 2021-09-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥7.322021-07-01 → 2021-09-30dCons.Diluted earnings loss per share IFRS
Equity ratio62.8%at 2022-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio62.3%at 2021-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio62.1%at 2021-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 26
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2022-01-01 → 2022-09-30−¥38m
Reconciling Itemsreconcilingrevenue intersegment2022-01-01 → 2022-09-30−¥38m
jpcrp040300-q3r_E05712-000Medical Devicereportable segmentrevenue2022-01-01 → 2022-09-30¥1.8bn
jpcrp040300-q3r_E05712-000Medical Devicereportable segmentrevenue external2022-01-01 → 2022-09-30¥1.7bn
jpcrp040300-q3r_E05712-000Medical Devicereportable segmentrevenue intersegment2022-01-01 → 2022-09-30¥38m
jpcrp040300-q3r_E05712-000Medical Devicereportable segmentsegment profit2022-01-01 → 2022-09-30¥699m
jpcrp040300-q3r_E05712-000Pharmaceuticalreportable segmentrevenue2022-01-01 → 2022-09-30¥11.0bn
jpcrp040300-q3r_E05712-000Pharmaceuticalreportable segmentrevenue external2022-01-01 → 2022-09-30¥11.0bn
jpcrp040300-q3r_E05712-000Pharmaceuticalreportable segmentsegment profit2022-01-01 → 2022-09-30¥796m
—segment totalrevenue2022-01-01 → 2022-09-30¥12.8bn
—segment totalrevenue external2022-01-01 → 2022-09-30¥12.8bn
—segment totalrevenue intersegment2022-01-01 → 2022-09-30¥38m
—segment totalsegment profit2022-01-01 → 2022-09-30¥1.5bn
Reconciling Itemsreconcilingrevenue2021-01-01 → 2021-09-30−¥35m
Reconciling Itemsreconcilingrevenue intersegment2021-01-01 → 2021-09-30−¥35m
jpcrp040300-q3r_E05712-000Medical Devicereportable segmentrevenue2021-01-01 → 2021-09-30¥1.5bn
jpcrp040300-q3r_E05712-000Medical Devicereportable segmentrevenue external2021-01-01 → 2021-09-30¥1.5bn
jpcrp040300-q3r_E05712-000Medical Devicereportable segmentrevenue intersegment2021-01-01 → 2021-09-30¥35m
jpcrp040300-q3r_E05712-000Medical Devicereportable segmentsegment profit2021-01-01 → 2021-09-30¥547m
jpcrp040300-q3r_E05712-000Pharmaceuticalreportable segmentrevenue2021-01-01 → 2021-09-30¥8.1bn
jpcrp040300-q3r_E05712-000Pharmaceuticalreportable segmentrevenue external2021-01-01 → 2021-09-30¥8.1bn
jpcrp040300-q3r_E05712-000Pharmaceuticalreportable segmentsegment profit2021-01-01 → 2021-09-30¥1.4bn
—segment totalrevenue2021-01-01 → 2021-09-30¥9.6bn
—segment totalrevenue external2021-01-01 → 2021-09-30¥9.5bn
—segment totalrevenue intersegment2021-01-01 → 2021-09-30¥35m
—segment totalsegment profit2021-01-01 → 2021-09-30¥2.0bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 716
ItemContextValueUnit
Current assets IFRSPrior1YearInstant18187002000JPY
Current assets IFRSCurrentQuarterInstant19248236000JPY
Assets IFRSPrior1YearInstant30296980000JPY
Assets IFRSCurrentQuarterInstant36456893000JPY
Lease liabilities ncl IFRSPrior1YearInstant280724000JPY
Lease liabilities ncl IFRSCurrentQuarterInstant226098000JPY
Deferred tax liabilities IFRSPrior1YearInstant501194000JPY
Deferred tax liabilities IFRSCurrentQuarterInstant744569000JPY
Other financial liabilities ncl IFRSPrior1YearInstant7539814000JPY
Other financial liabilities ncl IFRSCurrentQuarterInstant10441597000JPY
Other non current liabilities ncl IFRSPrior1YearInstant165840000JPY
Other non current liabilities ncl IFRSCurrentQuarterInstant181299000JPY
Non current labilities IFRSPrior1YearInstant8487574000JPY
Non current labilities IFRSCurrentQuarterInstant11593565000JPY
Trade and other payables cl IFRSPrior1YearInstant371138000JPY
Trade and other payables cl IFRSCurrentQuarterInstant556260000JPY
Borrowings cl IFRSPrior1YearInstant700000000JPY
Borrowings cl IFRSCurrentQuarterInstant500000000JPY
Lease liabilities cl IFRSPrior1YearInstant145662000JPY
Lease liabilities cl IFRSCurrentQuarterInstant164312000JPY
Income taxes payable cl IFRSPrior1YearInstant542019000JPY
Income taxes payable cl IFRSCurrentQuarterInstant403820000JPY
Other financial liabilities cl IFRSPrior1YearInstant6918000JPY
Other financial liabilities cl IFRSCurrentQuarterInstant7742000JPY
Other current liabilities cl IFRSPrior1YearInstant777420000JPY
Other current liabilities cl IFRSCurrentQuarterInstant1215524000JPY
Total current liabilities IFRSPrior1YearInstant2543159000JPY
Total current liabilities IFRSCurrentQuarterInstant2847659000JPY
Liabilities IFRSPrior1YearInstant11030734000JPY
Liabilities IFRSCurrentQuarterInstant14441225000JPY
Share capital IFRSPrior1YearInstant10884332000JPY
Share capital IFRSCurrentQuarterInstant10891191000JPY
Capital surplus IFRSPrior1YearInstant6224649000JPY
Capital surplus IFRSCurrentQuarterInstant6231481000JPY
Treasury shares IFRSPrior1YearInstant-645000JPY
Treasury shares IFRSCurrentQuarterInstant-645000JPY
Retained earnings IFRSPrior1YearInstant307535000JPY
Retained earnings IFRSCurrentQuarterInstant1383600000JPY
Other components of equity IFRSPrior1YearInstant1444437000JPY
Other components of equity IFRSCurrentQuarterInstant4402474000JPY
Equity attributable to owners of parent IFRSPrior1YearInstant18860309000JPY
Equity attributable to owners of parent IFRSCurrentQuarterInstant22908103000JPY
Non controlling interests IFRSPrior1YearInstant405936000JPY
Non controlling interests IFRSCurrentQuarterInstant-892434000JPY
Equity IFRSPrior1YearInstant19266246000JPY
Equity IFRSCurrentQuarterInstant22015668000JPY
Liabilities and equity IFRSPrior1YearInstant30296980000JPY
Liabilities and equity IFRSCurrentQuarterInstant36456893000JPY
Revenue IFRSPrior1YTDDuration9536714000JPY
Revenue IFRSCurrentYTDDuration12761031000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 16 of 16 passed
balance sheet identityconsolidated 2021-12-31pass
balance sheet identityconsolidated 2022-09-30pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2021-01-01/2021-09-30pass
statement vs summary · net income attributable to parentconsolidated 2021-07-01/2021-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-01-01/2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-07-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2021-01-01/2021-09-30pass
statement vs summary · operating cash flowconsolidated 2022-01-01/2022-09-30pass
statement vs summary · revenueconsolidated 2021-01-01/2021-09-30pass
statement vs summary · revenueconsolidated 2021-07-01/2021-09-30pass
statement vs summary · revenueconsolidated 2022-01-01/2022-09-30pass
statement vs summary · revenueconsolidated 2022-07-01/2022-09-30pass
statement vs summary · total assetsconsolidated 2021-12-31pass
statement vs summary · total assetsconsolidated 2022-09-30pass